Drugs / Veronate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00113191 | May 2004 → Jun 2006 | candidemia, infectious disease with sepsis, nosocomial infection, staphylococcal infection | Bristol-Myers Squibb | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Veronate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00113191 ↗ |
| Known as | INH-A21 | “infants with birth weights 500 to 1250 g were randomized to receive up to four doses of INH-A21 (Veronate) or placebo” PMID 17719934 ↗ Jul 2007 |